Electromed's Q4 revenue slightly beats estimates on homecare strength

Electromed repurchased $3.9 million of its common stock in fiscal 2026.

The company did not provide specific financial guidance for the upcoming quarter or fiscal year in its press release.

The US airway clearance device maker said Q4 revenue growth was primarily driven by increased direct sales representatives, higher sales rep productivity, and improved net revenue per approval.

Electromed also said Q4 gross profit and margin improved because of higher revenue and increased net revenue per device.

Electromed's fiscal fourth-quarter revenue rose, slightly beating analyst expectations, as homecare strength supported results.

• Q4 revenue: $19.40 million vs. consensus $19.33 million from three analysts
• Q4 EPS: $0.39
• Q4 net income: $3.40 million, up 54%, and above the $2.73 million consensus from three analysts
• Q4 operating income: $3.80 million